nsc-352122 and Acquired-Immunodeficiency-Syndrome

nsc-352122 has been researched along with Acquired-Immunodeficiency-Syndrome* in 3 studies

3 other study(ies) available for nsc-352122 and Acquired-Immunodeficiency-Syndrome

Article	Year
Drugs for AIDS and associated infections. The Medical letter on drugs and therapeutics, 1995, Oct-13, Volume: 37, Issue:959 Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine	1995
AIDS drug available. Journal of the California Dental Association, 1988, Volume: 16, Issue:12 Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Glucuronates; Humans; Pneumonia, Pneumocystis; Quinazolines; Trimetrexate	1988
FDA bends rules on experimental AIDS drug. Dental economics - oral hygiene, 1988, Volume: 78, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Drug Combinations; Glucuronates; Health Policy; Humans; Public Health; Quinazolines; Trimetrexate; United States; United States Food and Drug Administration	1988